Clinical Trial Update: The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection [Phase 3]

View source ↗

Summary

Phase 3 trial investigating sphenopalatine ganglion block versus placebo for persistent headache after COVID-19; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Post-covid-19 Headache

Drugs mentioned

• Sphenopalatine ganglion block

Snippet

Sponsor: University Hospital Bispebjerg and Frederiksberg | Conditions: Headache, Covid19 | Phase 3 | Status: TERMINATED